Telehealth platform Hims & Hers will begin offering a generic version of liraglutide, a GLP-1 weight loss drug, to its customers in 2025, Quartz reported Nov. 4.
Hims & Hers Health reported third-quarter results that topped Street expectations Monday and said it plans to release a ...
CVS Caremark and Express Scripts, along with GoodRx and others, are accused of working together to suppress reimbursements to independent pharmacies in at least three class-action lawsuits. Also, Hims ...
The millennial-skewed telehealth platform Hims & Hers (HIMS) announced Monday that it will start offering customers a generic version of liraglutide, an older GLP-1 weight loss drug, next year. The ...
12hon MSN
Telehealth company Hims & Hers said late Monday in an earnings update that it plans to launch a generic version of Novo ...
Hims & Hers Health (HIMS) stock gains after its Q3 2024 results as company plans to launch a generic version of Novo ...
Hims & Hers currently offers compounded GLP-1 weight-loss injections at $199 per month and weight management oral medication ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback